Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. PPCB
PPCB logo

PPCB

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PPCB News

Propanc Biopharma Shares Surge 200% Amid Buyback Program

Jun 11 2026stocktwits

Propanc Biopharma Authorizes $5M Share Buyback Program

Jun 11 2026NASDAQ.COM

ShareStructure.io Launches Free Financial Education Platform

Jun 11 2026Newsfilter

Propanc Biopharma Approves $5M Share Repurchase Program

Jun 11 2026seekingalpha

Propanc Approves $5 Million Share Repurchase Program

Jun 11 2026Newsfilter

Propanc Biopharma CEO Attends Keynote Address on Aging Science

Jun 02 2026Newsfilter

Propanc Biopharma Announces 1-for-25 Reverse Stock Split

May 14 2026Newsfilter

Propanc Biopharma Reports H1 2023 Financial Results

Feb 18 2026seekingalpha

Propanc Publishes Key Findings on PRP's Potential Efficacy Against Pancreatic Cancer

Dec 22 2025Globenewswire

Propanc Biopharma, Inc. Obtains Up to $100 Million in Private Placement to Enhance Digital Asset Acquisition and Speed Up R&D Initiatives

Nov 10 2025Newsfilter

Correction: Propanc Biopharma Reveals Strategic Financing Deal Worth Up to $100 Million with Hexstone Capital

Oct 15 2025Newsfilter

Propanc Shares Key Highlights from Fiscal Year End and Details on Therapeutic Development & $100M+ Digital Asset Treasury Plan

Oct 07 2025Newsfilter

Propanc Biopharma reveals intention to purchase $100 million in Ethereum

Sep 02 2025SeekingAlpha

Propanc Biopharma Issues Update for Shareholders

Aug 25 2025Newsfilter

Rocket Pharmaceuticals Shares Surge Over 15%; Check Out 20 Stocks Making Moves in Premarket Trading

Aug 20 2025Benzinga

What’s Happening with Propanc Shares This Monday?

Aug 18 2025Benzinga